CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 55:45 Family Friday: Reflecting on Adjusting to a New Diagnosis 5 years ago Family Friday,Webinars 59:37 Capricor’s HOPE-2 Final 12-Month Data (June 3, 2020) 5 years ago Research & Clinical Trial Webinars,Webinars 45:44 Family Friday: End of the School Year & Looking Ahead 5 years ago Family Friday,Webinars 48:02 Family Friday: Sibling Relationships 5 years ago Family Friday,Webinars 1:02:19 Making the Most of Your Telehealth Appointments (May 6, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 47:30 Family Friday: Managing Learning Challenges at Home 5 years ago Family Friday,Webinars 1:00:26 Access to Approved Therapies and Home Care (April 29, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 54:06 Italfarmaco Provides Givinostat Update (April 22, 2020) 5 years ago Research & Clinical Trial Webinars,Webinars «1…1011121314…25»Page 12 of 25
by: Parent Project Muscular Dystrophy
